These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24849843)

  • 1. Managing competing demands in the implementation of response-adaptive randomization in a large multicenter phase III acute stroke trial.
    Zhao W; Durkalski V
    Stat Med; 2014 Oct; 33(23):4043-52. PubMed ID: 24849843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive Randomization Method to Prevent Extreme Instances of Group Size and Covariate Imbalance in Stroke Trials.
    Italiano D; Campbell B; Hill MD; Johns HT; Churilov L
    Stroke; 2024 Aug; 55(8):1962-1972. PubMed ID: 38920051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal sufficient balance-a new strategy to balance baseline covariates and preserve randomness of treatment allocation.
    Zhao W; Hill MD; Palesch Y
    Stat Methods Med Res; 2015 Dec; 24(6):989-1002. PubMed ID: 22287602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal Randomization Designs for Large Multicenter Clinical Trials: From the National Institutes of Health Stroke Trials Network Funded by National Institutes of Health/National Institute of Neurological Disorders and Stroke Experience.
    Zhao W; Yeatts SD; Broderick JP; Selim MH; Adeoye OM; Durkalski-Mauldin VL; Meinzer CN; Martin RH; Dillon CR; Cassarly CN; Pauls KH; Elm JJ
    Stroke; 2023 Jul; 54(7):1909-1919. PubMed ID: 37078281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A class of Covariate-Adjusted Response-Adaptive Allocation Designs for Multitreatment Binary Response Trials.
    Biswas A; Bhattacharya R
    J Biopharm Stat; 2018; 28(5):809-823. PubMed ID: 29913107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient, dose-adaptive, seamless phase II/III design.
    Levin B; Thompson JL; Chakraborty B; Levy G; MacArthur R; Haley EC
    Clin Trials; 2011 Aug; 8(4):398-407. PubMed ID: 21737464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of statistical and operational properties of subject randomization procedures for large multicenter clinical trial treating medical emergencies.
    Zhao W; Mu Y; Tayama D; Yeatts SD
    Contemp Clin Trials; 2015 Mar; 41():211-8. PubMed ID: 25638754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Bayesian response-adaptive covariate-balanced randomization design with application to a leukemia clinical trial.
    Yuan Y; Huang X; Liu S
    Stat Med; 2011 May; 30(11):1218-29. PubMed ID: 21432894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simulation study for comparing testing statistics in response-adaptive randomization.
    Gu X; Lee JJ
    BMC Med Res Methodol; 2010 Jun; 10():48. PubMed ID: 20525382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical inference for response adaptive randomization procedures with adjusted optimal allocation proportions.
    Zhu H
    J Biopharm Stat; 2017; 27(5):732-740. PubMed ID: 27937121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of simulation to compare the performance of minimization with stratified blocked randomization.
    Toorawa R; Adena M; Donovan M; Jones S; Conlon J
    Pharm Stat; 2009; 8(4):264-78. PubMed ID: 18756580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using a balancing procedure in multicenter clinical trials. Simulation of patient allocation based on a trial of ventilation tubes for otitis media with effusion in infants.
    Rovers MM; Straatman H; Zielhuis GA; Ingels K; van der Wilt GJ
    Int J Technol Assess Health Care; 2000; 16(1):276-81. PubMed ID: 10815372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Step-forward randomization in multicenter emergency treatment clinical trials.
    Zhao W; Ciolino J; Palesch Y
    Acad Emerg Med; 2010 Jun; 17(6):659-65. PubMed ID: 20624149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomization in substance abuse clinical trials.
    Hedden SL; Woolson RF; Malcolm RJ
    Subst Abuse Treat Prev Policy; 2006 Feb; 1():6. PubMed ID: 16722591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response-adaptive decision-theoretic trial design: operating characteristics and ethics.
    Lipsky AM; Lewis RJ
    Stat Med; 2013 Sep; 32(21):3752-65. PubMed ID: 23558674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive survival trials.
    Rosenberger WF; Seshaiyer P
    J Biopharm Stat; 1997 Nov; 7(4):617-24. PubMed ID: 9358333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of minimal sufficient balance, minimization, and stratified permuted blocks on bias and power in the estimation of treatment effect in sequential clinical trials with a binary endpoint.
    Lauzon SD; Zhao W; Nietert PJ; Ciolino JD; Hill MD; Ramakrishnan V
    Stat Methods Med Res; 2022 Jan; 31(1):184-204. PubMed ID: 34841963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editors' comments on a new trial of activated protein C for persistent septic shock.
    Mancebo J; Antonelli M
    Intensive Care Med; 2008 Nov; 34(11):1948-9. PubMed ID: 18839138
    [No Abstract]   [Full Text] [Related]  

  • 19. Response-adaptive randomization for clinical trials with adjustment for covariate imbalance.
    Ning J; Huang X
    Stat Med; 2010 Jul; 29(17):1761-8. PubMed ID: 20658546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization.
    Ciolino J; Zhao W; Martin R; Palesch Y
    Contemp Clin Trials; 2011 Mar; 32(2):250-9. PubMed ID: 21078415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.